semaglutide for type 2 diabetes Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication adults with diabetes, soon to be available in the US Semaglutide (Ozempic/Wegovy) shows 3-year efficacy
Description
1, Sept
Currently, only Wegovy is approved for weight loss in the United States
After about 45 weeks of consistent use, levels stabilize in what is known as steady state, meaning the medication maintains relatively consistent levels in the body
HPLC-verified 99% purity, lot-specific Certificate of Analysis included
Your provider recommends the program that fits your health profile after reviewing your intake
Phase 2 trial data (NEJM, 2023) showed a mean body weight reduction of approximately 24% at the highest dose (12 mg weekly) over 48 weeks in adults without type 2 diabetes
